arrow
J

Jens Dahlgaard Hove

University of Copenhagen
H指数:30
被引数:5,255

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Association between interleukin-6, suPAR, and hsCRP with subclinical left ventricular dysfunction in type 1 diabetes: The Thousand & 1 study” [Diabetes Res. Clin. Pract. 222 (2025) 112071]

对“白细胞介素-6、suPAR和hsCRP与1型糖尿病亚临床左心室功能不全的相关性:千与千寻研究”[Diabetes Res. Clin. Pract. 222 (2025) 112071]的勘误

2026-07-010
OAAI
Effects of exercise and liraglutide on vascular health and inflammation during weight loss maintenance: a prespecified secondary analysis of the S-LiTE trial

运动和利拉鲁肽对体重维持期间血管健康和炎症的影响:S-LiTE试验的事先预定的二次分析

2026-06-240
OAAI
Glucocorticoids for Patients With Acute Decompensated Heart Failure: A Protocol for a Systematic Review With Meta-Analysis and Trial Sequential Analysis

糖皮质激素用于急性失代偿性心力衰竭患者:一项系统评价与Meta分析及试验序贯分析的方案

2026-05-220
PRE
Restrictive versus liberal oxygenation targets in patients with acute heart failure and pulmonary congestion-A protocol for a Randomized Controlled Trial (The REDOX-AHF trial)

限制性与宽松氧合目标在急性心力衰竭伴肺淤血患者中的应用——一项随机对照试验的方案(REDOX-AHF试验)

2026-05-011
PRE
Optimizing diagnostic resource use in suspected chronic coronary syndrome: pre-test probability and acoustic CAD rule-out in the FILTER-SCAD trial

优化可疑慢性冠状动脉综合征的诊断资源利用:FILTER-SCAD试验中的术前概率和声学计算机辅助诊断排除标准

2026-03-010
PRE
Coronary Computed Tomography Angiography Versus Invasive Coronary Angiography for Interventional Triage in Acute Coronary Syndrome – Design of the Randomized TRACTION Trial

冠状动脉计算机断层扫描血管造影与侵入性冠状动脉血管造影在急性冠状动脉综合征介入治疗中的比较——TRACTION随机试验的设计

2025-12-060
OAAI
Cardiovascular effects of incretin-based drugs in patients with and without a history of heart failure: a protocol for a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials

基于肠促胰岛素药物的药物在有心衰史和无心衰史患者中的心血管效应:一项系统综述、荟萃分析及随机对照试验的试验序贯分析方案

2025-09-210
OAAI
Should exogenous ketone body supplementation be considered in patients hospitalized for acute heart failure? Rationale and design of the KETO-AHF trial

急性心力衰竭住院患者是否应考虑外源性酮体补充?KETO-AHF试验的依据与设计

2025-08-090
PREAI
Soluble urokinase plasminogen activator receptor and interleukin-6 improves prediction of all-cause mortality and major adverse cardiovascular events in Type 1 diabetes

可溶性尿激酶型纤溶酶原激活剂受体和白介素-6可改善对1型糖尿病患者全因死亡和主要不良心血管事件的预测

2025-07-070
OAAI
Inflammation and risk of cardiovascular outcomes in patients with atrial fibrillation and flutter: A nationwide registry study

心房颤动和心房扑动患者中的炎症与心血管结局风险:一项全国登记研究

2025-05-290
PRE